Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Cisplatin in Pediatric Gliomas
NCT01574092Phase 2Completed
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Nov 2009
- Primary completion
- Jun 2014
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in glioma, sponsored by Sant Joan de Déu Hospital. Started Nov 2009; status: completed.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01574092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574092.